No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Biaxin (clarithromycin) is an antibiotic used to treat a variety of respiratory infections, including bronchitis, pneumonia, and sinusitis. It is a macrolide antibiotic, which works by stopping the growth of bacteria. Biaxin is available in both oral and intravenous forms, and is often prescribed in combination with other medications. It is generally well-tolerated, but can cause side effects such as nausea, vomiting, and diarrhea.
The Biaxin market is a subset of the larger respiratory drugs market, which includes medications used to treat a variety of respiratory conditions. These drugs are used to treat both acute and chronic respiratory illnesses, and can be administered orally, intravenously, or through inhalation. The respiratory drugs market is highly competitive, with many different companies offering a variety of products.
Some of the companies in the Biaxin market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more
